The Defense Logistics Agency (DLA) awarded a $1,828.50 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4565765799 - MOUNJARO 10 MG/0.5 ML PEN 0.5ML. This contract award, identified as SPE2DB24FJTMQ, has an ultimate completion date of September 9, 2024.
Dakota Drug, Inc. is a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, primarily the Department of Defense. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00, which allows it to provide a comprehensive range of medical items to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program. This latest award further demonstrates Dakota Drug, Inc.'s important position within the DLA's medical supply chain.
Generated 12/6/24, 9:33 AM